BioSpace News Archive

Cybin Inc. announces the availability of a broadcast titled, “Science Drives Surging Interest in Psychedelic Therapeutics.”.

TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (“TFF”) technology platform, today announced that it has priced an underwritten offering of 2,855,000 shares of its common stock

Cerner Corporation (Nasdaq: CERN), a global health care technology company, today announced that its Board of Directors declared a cash dividend to stockholders of $0.22 per issued and outstanding share.

Kintor Pharmaceutical Limited (stock code 9939.HK, “Kintor Pharmaceutical” or the “Company”), a clinical-stage biotechnology company developing small molecule and biological therapeutics, recently announced its business highlights and financial results for the year ended December 31, 2020.

- The American Cancer Society (ACS) is a global grassroots force of nearly 2 million volunteers dedicated to saving lives, celebrating lives, and leading the fight for a world without cancer. Those essential volunteers also include the 17 Tennessee American Cancer Society Area Board Members.

Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) announced today that the U.S. Food and Drug Administration (FDA) approved Myrbetriq® (mirabegron extended-release tablets) for the treatment of NDO in pediatric patients aged three years and older who weigh 35 kg or more, and Myrbetriq® Granules

3ive Labs, a medical device product development organization focused on treating kidney disease, today announces the appointment of Lance Black, MD, MBID as Senior Medical Director.

Camurus today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency’s (EMA) has issued a positive opinion recommending marketing authorization for a new, 160mg, monthly dose of Buvidal®

In 2020, Cosmo received European approval for Methylene Blue MMX®, received FDA approval for BYFAVO™, continued to execute its equity for product strategy and has returned to operating profit.

At ENC 2021, Bruker Showcases Enhanced Benchtop Fourier 80™ FT-NMR, Affordable AvanceCore™ 400 NMR, and Versatile Benchtop Magnettech™ ESR 5000